Hearing loss is experienced by over 1.5 billion people worldwide, a staggering statistic projected to reach the 2.5 billion mark before 2050. Much of the conversation surrounding hearing loss is centered around young peoples’ use of personal audio devices, which poses a significant risk due to unsafe decibel levels and an expedited damage timeline as compared to other forms of noise-induced hearing loss. However, the prevalence of inherited hearing loss, marked by genetic mutation, for which over 50% of cases qualify, is often underrepresented in such discourse.
A researcher on the vanguard of hearing disorders and auditory circuitry, Dr. Wei-Ming Yu, DVM, PhD, author of “Critical Role of Hepsin/TMPRSS1 in Hearing and Tectorial Membrane Morphogenesis,” presented his research process and findings in a recent talk at Loyola University Chicago, where he is an associate professor of biology. Given his background in developmental neurobiology and research interests, Yu conducted this study to better understand how hepsin, a type II transmembrane serine protease, functions in the development of the tectorial membrane. This inner-ear structure is critical for contraction of the inner and outer hair cells responsible for the mechanotransduction of sound waves into electrical signals, the underlying process of audition.
As with any organ as complex as the inner ear, a variety of proteins are crucial to proper functioning. In a similar fashion to Dr. Yu’s focus on Hepsin/TMPRSS1, other researchers in recent years have dialed in on other proteins involved in hearing loss and the tectorial membrane. A 2023 study entitled “Behavioral characterization of the cochlear amplifier lesion due to loss of function of stereocilin (STRC) in human subjects” focuses on stereocilin (STRC), a critical protein involved in inherited hearing loss, particularly in its unique role of facilitating connection between the outer hair cells (OHCs) and the tectorial membrane. Inherited stereocilin deficiency often results in pathologies regarding cochlear frequency selectivity and functionality, which significantly contribute to hearing loss in young patients, ranging from 7 to 24 years of age.
Perhaps the most remarkable aspect of this study is that researchers believe this to be the first study where psychacoustic performance of human subjects was examined, particularly with participants with “normal” inner hair cell functionality. Notably, these participants also lack cochlear amplification or assistive technology, a population that is often underrepresented in hearing loss research in favor of those with varying degrees of cochlear functionality deficiency.
This particular study and further research in the tectorial membrane allow for innovations in the fields of audiology, otolaryngology, and speech-language pathology, providing healthcare and biotechnology professionals with revolutionary insights into the connection between cochlear function and STRC mutations, whereby enhancements to assistive technology like hearing aids and cochlear implants are likely to emerge. Groundbreaking research like this is integral to the refinement of signal processing mechanisms in assistive hearing technology, improving the user experience for those experiencing hearing loss. Effective management of sensorineural hearing loss once solely relied on amplification devices; now, with advancements in genetics and regenerative medicine, healthcare professionals are better equipped to manage even the most profound levels of hearing loss.
References
Yang, T.-H., Hsu, Y.-C., Yeh, P., Hung, C.-J., Tsai, Y.-F., Fang, M.-C., Yen, A. C. C., Chen, L.-F., Pan, J.-Y., Wu, C.-C., Liu, T.-C., Chung, F.-L., Yu, W.-M., & Lin, S.-W. (2024). Critical role of hepsin/TMPRSS1 in hearing and tectorial membrane morphogenesis: Insights from transgenic mouse models. Hearing Research, 453, 1–15. https://doi.org/10.1016/j.heares.2024.109134
Benoit, C., Carlson, R. J., King, M.-C., Horn, D. L., & Rubinstein, J. T. (2023). Behavioral characterization of the cochlear amplifier lesion due to loss of function of stereocilin (STRC) in human subjects. Hearing Research, 439, 1–10. https://doi.org/10.1016/j.heares.2023.108898
No comments:
Post a Comment